1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CD73 + Epithelial Progenitor Cells That Contribute to Homeostasis and Renewal Are Depleted in Eosinophilic Esophagitis

      research-article
      1 , 1 , 2 , 1 , 1 , 1 , 3 , 4 , 5 , 6 , 5 , 6 , 5 , 6 , 1 , 1 , 1 , 1 , 1 , 7 , 8 , 9 , 1 , 9 , 8 , 9 , 1 , 3 , 4 , 5 , 6 , 1 , 9 ,
      Cellular and Molecular Gastroenterology and Hepatology
      Elsevier
      Eosinophilic Esophagitis, Epithelium, Organoids, CD73, CD104, BCH, basal cell hyperplasia, DAPI, 4’,6-diamidino-2-phenylindole, DEG, differentially expressed gene, EdU, ethynyldeoxyuridine, EGD, esophagogastroduodenoscopy, EoE, eosinophilic esophagitis, eos/hpf, esophageal mucosal eosinophils per high-power field, FACS, fluorescence-activated cell sorting, GO, Gene Ontology, IHC, immunohistochemistry, IL, interleukin, mRNA, messenger RNA, OFR, organoid formation rate, OVA, ova-albumin, PCA, principal component analysis, PDO, patient-derived organoid, PPI, proton pump inhibitor, qRT-PCR, quantitative reverse-transcription polymerase chain reaction, siRNA, small interfering RNA, STAT6, signal transducer and activator of transcription 6, 3D, 3-dimensional, Th, helper T cell

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background & Aims

          Although basal cell hyperplasia is a histologic hallmark of eosinophilic esophagitis (EoE), little is known about the capabilities of epithelial renewal and differentiation in the EoE inflammatory milieu. In murine esophageal epithelium, there are self-renewing and slowly proliferating basal stem-like cells characterized by concurrent expression of CD73 (5'-nucleotidase ecto) and CD104 (integrin β4). Here, we investigated CD73 +CD104 + cells within the basal population of human esophageal epithelium and clarified the biological significance of these cells in the EoE epithelium.

          Methods

          We performed flow cytometry on esophageal biopsy samples from EoE and non-EoE patients to determine the quantity of CD73 +CD104 + cells in the epithelium. Simulating the EoE milieu we stimulated primary patient-derived and immortalized cell line–derived esophageal organoids with interleukin (IL)4 and IL13 and analyzed by flow cytometry, immunohistochemistry, and quantitative reverse-transcription polymerase chain reaction. We performed single-cell RNA sequencing on primary organoids in the setting of IL13 stimulation and evaluated the CD73 +CD104 + population. We performed fluorescent-activated cell sorting to purify CD73 +CD104 + and CD73 - CD104 + populations and seeded these groups in organoid culture to evaluate the organoid formation rate and organoid size. We used RNA interference to knock down CD73 in esophageal organoids to evaluate organoid formation rates and size. We evaluated the effects of signal transducer and activator of transcription 6 (STAT6) signaling inhibition by RNA interference, a STAT6 inhibitor, AS1517499, as well as the proton pump inhibitor omeprazole.

          Results

          EoE patients showed decreased epithelial CD73 +CD104 + cell content. IL4 and IL13 stimulation depleted this population in 3-dimensional organoids with a recapitulation of basal cell hyperplasia as corroborated by single-cell RNA sequencing of the organoids, which suggests depletion of CD73 +CD104 + cells. The CD73 +CD104 + population had enhanced organoid formation compared with the CD73 -CD104 + population. Similarly, knock-down of CD73 resulted in decreased organoid formation rate. Genetic and pharmacologic inhibition of STAT6 prevented T helper 2 cytokine-induced depletion of CD73 +CD104 + cells. Lastly, omeprazole treatment prevented the effects of IL4 and IL13 on the CD73 +CD104 + population.

          Conclusions

          This study addressed the role of CD73 +CD104 + cells in epithelial renewal and homeostasis in the context of EoE. The depletion of the CD73 +CD104 + self-renewal population by helper T cell 2 cytokines in EoE milieu may be perpetuating epithelial injury. Future therapies targeting epithelial restitution in EoE could decrease the need for immune modulation and steroid therapy.

          Graphical abstract

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.

          Adenosine is a key endogenous molecule that regulates tissue function by activating four G-protein-coupled adenosine receptors: A1, A2A, A2B and A3. Cells of the immune system express these receptors and are responsive to the modulatory effects of adenosine in an inflammatory environment. Animal models of asthma, ischaemia, arthritis, sepsis, inflammatory bowel disease and wound healing have helped to elucidate the regulatory roles of the various adenosine receptors in dictating the development and progression of disease. This recent heightened awareness of the role of adenosine in the control of immune and inflammatory systems has generated excitement regarding the potential use of adenosine-receptor-based therapies in the treatment of infection, autoimmunity, ischaemia and degenerative diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

            Background and Aims: Over the last decade, clinical experiences and research studies raised concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for eosinophilic esophagitis (EoE). We aimed to clarify the use of PPIs in the evaluation and treatment of children and adults with suspected EoE in order to develop updated international consensus criteria for EoE diagnosis. Methods: A consensus conference was convened to address the issue of PPI use for esophageal eosinophilia using a process consistent with standards described in the Appraisal of Guidelines for Research and Evaluation II. Pediatric and adult physicians and researchers from gastroenterology, allergy, and pathology subspecialties representing 14 countries utilized on-line communications, teleconferences, and a face-to-face meeting to review the literature and clinical experiences. Results: Substantial evidence documented that PPIs reduce esophageal eosinophilia in children, adolescents and adults, with several mechanisms potentially explaining the treatment effect. Based on these findings, an updated diagnostic algorithm for EoE was developed, with removal of the PPI trial requirement. Conclusions: EoE should be diagnosed when there are symptoms of esophageal dysfunction and at least 15 eosinophils per high-power field (or ~60 eosinophils per mm 2 ) on esophageal biopsy, and after a comprehensive assessment of non-EoE disorders that could cause or potentially contribute to esophageal eosinophilia. The evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EoE than as a diagnostic criterion, and we have developed updated consensus criteria for EoE that reflect this change.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

              Eosinophilic esophagitis (EoE) is an allergen-mediated inflammatory disease with no approved treatment in the United States. Dupilumab, a VelocImmune-derived human monoclonal antibody against the interleukin (IL) 4 receptor, inhibits IL4 and IL13 signaling. Dupilumab is effective in the treatment of allergic, atopic, and type 2 diseases, so we assessed its efficacy and safety in patients with EoE.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell Mol Gastroenterol Hepatol
                Cell Mol Gastroenterol Hepatol
                Cellular and Molecular Gastroenterology and Hepatology
                Elsevier
                2352-345X
                2022
                30 January 2022
                : 13
                : 5
                : 1449-1467
                Affiliations
                [1 ]Division of Pediatric Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
                [2 ]Department of Surgery, National Hospital Organization, Fukuokahigashi Medical Center, Koga, Fukuoka, Japan
                [3 ]Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania
                [4 ]Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania
                [5 ]Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons
                [6 ]Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York
                [7 ]Division of Gastroenterology, Department of Medicine, Philadelphia, University of Pennsylvania, Pennsylvania
                [8 ]Division of Allergy and Immunology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
                [9 ]Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
                Author notes
                [] Correspondence Address correspondence to Amanda B. Muir, MD, Division of Gastroenterology, Abramson Research Center, Perlman School of Medicine, University of Pennsylvania, 3615 Civic Center Boulevard, 902E, Philadelphia, Pennsylvania 19104-6160. fax: (215) 590-3606 muira@ 123456email.chop.edu
                Article
                S2352-345X(22)00018-2
                10.1016/j.jcmgh.2022.01.018
                8957025
                35108658
                999cd9ec-7f07-4bd4-a6f3-8f35dd2af813
                © 2022 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 26 April 2021
                : 21 January 2022
                Categories
                Original Research

                eosinophilic esophagitis,epithelium,organoids,cd73,cd104,bch, basal cell hyperplasia,dapi, 4’,6-diamidino-2-phenylindole,deg, differentially expressed gene,edu, ethynyldeoxyuridine,egd, esophagogastroduodenoscopy,eoe, eosinophilic esophagitis,eos/hpf, esophageal mucosal eosinophils per high-power field,facs, fluorescence-activated cell sorting,go, gene ontology,ihc, immunohistochemistry,il, interleukin,mrna, messenger rna,ofr, organoid formation rate,ova, ova-albumin,pca, principal component analysis,pdo, patient-derived organoid,ppi, proton pump inhibitor,qrt-pcr, quantitative reverse-transcription polymerase chain reaction,sirna, small interfering rna,stat6, signal transducer and activator of transcription 6,3d, 3-dimensional,th, helper t cell

                Comments

                Comment on this article